Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
88.00
+2.20 (2.56%)
Aug 12, 2025, 4:00 PM - Market closed
Revvity Employees
Revvity had 11,000 employees as of December 29, 2024. The number of employees decreased by 500 or -4.35% compared to the previous year.
Employees
11,000
Change (1Y)
-500
Growth (1Y)
-4.35%
Revenue / Employee
$254,406
Profits / Employee
$25,927
Market Cap
10.21B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 11,000 | -500 | -4.35% |
Dec 31, 2023 | 11,500 | -5,200 | -31.14% |
Dec 31, 2022 | 16,700 | 0 | - |
Dec 31, 2021 | 16,700 | 2,700 | 19.29% |
Dec 31, 2020 | 14,000 | 1,000 | 7.69% |
Dec 31, 2019 | 13,000 | 500 | 4.00% |
Dec 31, 2018 | 12,500 | 1,500 | 13.64% |
Dec 31, 2017 | 11,000 | 3,000 | 37.50% |
Dec 31, 2016 | 8,000 | 0 | - |
Dec 31, 2015 | 8,000 | 300 | 3.90% |
Dec 31, 2014 | 7,700 | 100 | 1.32% |
Dec 31, 2013 | 7,600 | 100 | 1.33% |
Dec 31, 2012 | 7,500 | 300 | 4.17% |
Dec 31, 2011 | 7,200 | 1,000 | 16.13% |
Dec 31, 2010 | 6,200 | -2,000 | -24.39% |
Dec 31, 2009 | 8,200 | 300 | 3.80% |
Dec 31, 2008 | 7,900 | -800 | -9.20% |
Dec 31, 2007 | 8,700 | 200 | 2.35% |
Dec 31, 2006 | 8,500 | 500 | 6.25% |
Dec 31, 2005 | 8,000 | -2,000 | -20.00% |
Dec 31, 2004 | 10,000 | 0 | - |
Dec 31, 2003 | 10,000 | -700 | -6.54% |
Dec 31, 2002 | 10,700 | -100 | -0.93% |
Dec 31, 2001 | 10,800 | -1,700 | -13.60% |
Dec 31, 2000 | 12,500 | 500 | 4.17% |
Dec 31, 1999 | 12,000 | -1,000 | -7.69% |
Dec 31, 1998 | 13,000 | -1,000 | -7.14% |
Dec 31, 1997 | 14,000 | -1,000 | -6.67% |
Dec 31, 1996 | 15,000 | 0 | - |
Dec 31, 1995 | 15,000 | -10,000 | -40.00% |
Dec 31, 1994 | 25,000 | -7,000 | -21.88% |
Dec 31, 1993 | 32,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RVTY News
- 6 days ago - Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics - Business Wire
- 15 days ago - Revvity Q2: Headwinds From China And Customers, Buy On Weakness - Seeking Alpha
- 15 days ago - Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook - Investopedia
- 15 days ago - Top Stock Movers Now: Nike, Cheniere Energy, Revvity, and More - Investopedia
- 15 days ago - Revvity, Inc. (RVTY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
- 15 days ago - Revvity trims 2025 profit forecast on soft demand for diagnostics in China - Reuters
- 15 days ago - Revvity Stock Tumbles After Earnings. What's Dragging on the Shares. - Barrons